Differentiation of Certain Platelet Factors Related to Blood Coagulation

No abstract is available for this paper.

• Publication year

  1955

• Venue

  Circulation Research

• Publication date

  1955-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.RES.3.1.110PMID 13231284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simple method for purifying an activator of prothrombin (antihemophilic factor?).

  1954cited by this paper
• Relationship of certain antihistamine drugs to the activation of purified prothrombin.

  1954cited by this paper
• [Purification and characterization of the VII blood coagulation factor].

  1953cited by this paper
• The formation of thromboplastin in human blood

  1953cited by this paper
• The existence of antifibrinolysin activity in platelets.

  1953cited by this paper
• The initial stages of blood coagulation

  1953cited by this paper
• Isolation and properties of the third clotting factor in blood-platelets.

  1952cited by this paper
• Plasma Throinboplastin Component (PTC) Deficiency

  1952cited by this paper
• Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.

  1952cited by this paper
• Platelets and their plasma cofactor activity in the activation of purified prothrombin.

  1952cited by this paper
• Die Blutplättchen und ihre Bedeutung für Blutungsneigung und Thrombusbildung

  1952cited by this paper
• Prothrombin, thromboplastin, Ac-globulin and platelet accelerator: quantitative interrelationships.

  1950cited by this paper
• Platelet extracts, fibrin formation and interaction of purified prothrombin and thromboplastin.

  1948cited by this paper
• Clotting of plasma and silicone surfaces.

  1948cited by this paper
• Studies on prothrombin; purification, inactivation with thrombin, and activation with thromboplastin and calcium.

  1948cited by this paper
• Observations on the Conversion of Prothrombin to Thrombin

  1947cited by this paper
• STUDIES ON THE ENIGMA OF THE HEMOSTATIC DYSFUNCTION OF HEMOPHILIA

  1947cited by this paper
• FACTORS WHICH INFLUENCE THE ACTIVITY OF PURIFIED THROMBIN

  1942cited by this paper
• THE THROMBOPLASTIN REAGENT FOR THE DETERMINATION OF PROTHROMBIN.

  1940cited by this paper

• Research progress on platelet factor 4 in improving cognition.

  2025cites this paper
• Platelet Factor 4: A Mysterious Chemokine in Inflammatory Regulation Diseases

  2025cites this paper
• Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review

  2023cites this paper
• The immunology of PF4 polyanion interactions

  2023cites this paper
• Platelet factor 4(PF4) and its multiple roles in diseases.

  2023cites this paper
• Glycosaminoglycans: Participants in Microvascular Coagulation of Sepsis

  2023cites this paper
• Modeling uniquely human gene regulatory function via targeted humanization of the mouse genome

  2022cites this paper
• Chemokine signaling in cancer-stroma communications

  2021cites this paper
• The Human Accelerated Region HACNS1 modifies developmental gene expression in humanized mice

  2019cites this paper
• Radionuclide-Labeled Peptides for Imaging and Treatment of CXCR4- Overexpressing Malignant Tumors.

  2019cites this paper
• Modeling uniquely human gene regulatory function in humanized mice

  2019cites this paper
• Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality

  2018cites this paper
• Nanoparticules polymères ciblant le récepteur CXCR3 : élaboration et évaluation sur modèles de tumeur

  2018cites this paper
• Chemokine Receptor Signaling and the Hallmarks of Cancer.

  2017cites this paper
• Anti-CXCL4 monoclonal antibody accelerates telogen to anagen transition and attenuates apoptosis of the hair follicle in mice

  2017cites this paper
• Suppression of the CXCL4-JNK pathways contributes to the attenuation of DSS-induced acute colitis in mice

  2016cites this paper
• An investigation into the role of chemokines in haemopoietic stem cell quiescence

  2015cites this paper
• Generation and Characterization of a New Monoclonal Antibody Against CXCL4

  2015cites this paper
• The roles and potential therapeutic implications of CXCL4 and its variant CXCL4L1 in the pathogenesis of chronic liver allograft dysfunction.

  2015cites this paper
• Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets

  2013cites this paper
• Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy.

  2013cites this paper
• CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer.

  2012cites this paper
• The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.

  2011cites this paper
• Platelet Factor 4 (PF‐4) A Study on Methodology and Physiology

  2009cites this paper
• What for platelet factor 4

  2007cites this paper
• Beitrag zur Differenzierung und Therapie der hämophilen Gerinnungsstörung

  2004cites this paper
• Chemokines and renal disease.

  1995cites this paper
• The nomenclature of chemokines.

  1995cites this paper
• Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes

  1993cites this paper
• Biochemical studies on sulfated lactobionic acid amides.

  1991cites this paper
• Biology of the RANTES/SIS cytokine family.

  1991cites this paper
• 1H-NMR studies of bovine platelet factor 4: histidine assignments and interactions with heparin.

  1991cites this paper
• Influence of Platelet Factor 4 on the Neutralization of Heparin by Protamine a

  1989cites this paper
• Thrombo-embolic complications after splenectomy in HbE-beta-thalassaemia.

  1988cites this paper
• Caffey disease responding to high-dose immunoglobulin

  1988cites this paper
• Thrombo-embolic complications after splenectomy in HbE-β-Thalassaemia

  1988cites this paper
• Isolation and amino acid sequence of bovine platelet factor 4.

  1986cites this paper
• In Vivo Studies on the Binding of Heparin and Its Fractions with Platelet Factor 4

  1985cites this paper
• Amino acid sequence homology between bovine and human platelet proteins.

  1985cites this paper
• Platelet-Released Proteins as Molecular Markers for the Activation Process

  1984cites this paper
• The Effect of Collagen Mediated Platelet Release on Plasma Prekallikrein Activation

  1984cites this paper
• Platelet Structure and Function

  1983cites this paper
• A platelet derived inhibitor of plasma prekallikrein activation.

  1983cites this paper
• Surface-governed molecular regulation of blood coagulation.

  1983cites this paper
• Radioimmunoassay of platelet factor 4.

  1982cites this paper
• BOVINE PLATELET ANTIHEPARIN PROTEIN: PLATELET FACTOR 4 *

  1981cites this paper
• X. Platelets, Phospholipids and Platelet Cofactors

  1981cites this paper
• Differentiation of factor V-like coagulant activity from catalytic phospholipid-like surface activity in membrane fractions derived from human platelets.

  1981cites this paper
• A personal perspective on hemostasis and thrombosis (1937-1981).

  1981cites this paper
• THE PLATELET MEMBRANE AS A CATALYTIC SURFACE IN THROMBIN GENERATION: AVAILABILITY OF PLATELET FACTOR 1 AND PLATELET FACTOR 3 *

  1981cites this paper
• Factors affecting human platelet function in relation to atherosclerosis

  1980cites this paper
• Plasma protein regulation of platelet function and metabolism

  1979cites this paper
• Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassay.

  1979cites this paper
• Proteins secreted by platelets: significance in detecting thrombosis.

  1978cites this paper
• Heparin neutralizing activity and coronary artery disease.

  1977cites this paper
• Impaired anticoagulant effect of heparin in the artificial kidney. An experimental study.

  1976cites this paper
• Factor V.

  1976cites this paper
• [12] Factor V

  1976cites this paper
• Prothrombin complex proteins as cofactors in platelet aggregation. I. Inhibition of aggregation by antiserum.

  1975cites this paper
• Prothrombin complex proteins as cofactors in platelet aggregation. I. Inhibition of aggregation by antiserum

  1975cites this paper
• Complications of heparin therapy.

  1975cites this paper
• Platelet factor 4 (PF-4). A study on methodology and physiology.

  1974cites this paper
• PLASMA PROTEIN REQUIREMENTS FOR HUMAN PLATELET AGGREGATION

  1972cites this paper
• Platelet factor-4--properties and clinical significance.

  1972cites this paper
• 11 – ROLE OF PLATELETS IN BLOOD CLOTTING

  1971cites this paper
• 15 – CLINICAL DISORDERS RELATED TO BLOOD PLATELETS

  1971cites this paper
• Platelets in Hemostasis

  1967cites this paper
• CHAPTER 5 – Immunochemistry

  1967cites this paper
• Quantitative und qualitative Befunde zur Beurteilung von Blutgerinnung und Blutstillung

  1967cites this paper
• Rôle of Thrombin in Prothrombin Activation

  1964cites this paper
• INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.

  1964cites this paper
• A Comparison of the Effect of Platelets and Erythrocytes on the Inhibitory Action of Blood Coagulation by Polybrene and Heparin

  1964cites this paper
• Purification and some properties of autoprothrombin C.

  1963cites this paper
• Activation of coagulation and fibrinogen loss after using an extracorporeal circulation

  1963cites this paper
• The antiheparin effect of platelets.

  1962cites this paper
• Autoprothrombin C: a second enzyme from prothrombin.

  1962cites this paper
• Heparin Resistance, Thromboplastin Generation and Glass Activation

  1961cites this paper
• Quantitative und qualitative Störungen der Thrombozyten nach Injektion hochmolekularer Polymerer

  1961cites this paper
• [Quantitative and qualitative disorders of the thrombocytes after injection of high molecular polymers. (A contribution to the Sanarelli-Shwartzman phenomenon)].

  1961cites this paper
• Reticuloendothelial Clearance of Blood Thromboplastin by Rats

  1961cites this paper
• The effect of Polybrene on blood coagulation. In vitro.

  1961cites this paper
• The platelet as a sponge: a review.

  1961cites this paper
• Association of an inhibitor with deficiency of plasma-clearing activity.

  1961cites this paper
• [The Sanarelli-Shwartzman phenomenon in febrile abortions and severe shock and hemorrhagic conditions in obstetrics].

  1960cites this paper
• [Heparin tolerance and blood coagulation factors in obliterating arteriopathy].

  1960cites this paper
• The effect of heparin on plasma thromboplastin formation.

  1959cites this paper
• [Localization of blood coagulation physiological activities in submicroscopic structures of thrombocytes].

  1959cites this paper
• [A simple method for determination of thrombocyte factor 4].

  1959cites this paper
• Über die Antithrombinwirkung des Heparins unter dem Einfluß aktivierender und hemmender Faktoren

  1959cites this paper
• Über die Lokalisierung von gerinnungsphysiologischen Aktivitäten in submikroskopischen Strukturen der Thrombocyten

  1959cites this paper
• THE COAGULATION PROPERTIES OF HUMAN ERYTHROCYTES

  1959cites this paper
• [Hemorrhage caused by disorder of thrombocyte function; a case of familial thrombopathy].

  1958cites this paper
• Platelet factor 1 related to prothrombin activation.

  1958cites this paper
• PHOSPHATIDES AS PLATELET SUBSTITUTES IN BLOOD COAGULATION *

  1958cites this paper
• [Hereditary hemorrhagic diathesis with prolonged bleeding time, partial deficiency of anti-hemophilic globulin A and a functional disorder of some thrombocyte factors].

  1958cites this paper
• Übereine hereditäre hämorrhagische Diathese mit verlängerter Blutungszeit, partiellem Mangel an antihämophilem Globulin A und einer funktionellen Störung einzelner Thrombozytenfaktoren

  1958cites this paper
• [Research on the chemical identification & synthesis of coagulation factors].

  1957cites this paper
• [Studies on lipoid activator of blood coagulation].

  1957cites this paper
• Hemorrhagic disease in osteogenesis imperfecta; study of platelet functional defect.

  1957cites this paper
• Influence of Thrombin on Rate of Prothrombin Conversion

  1957cites this paper